Company research
Electromedical Technologies, Inc
CIK 1715819Updated Sep 24, 2026
SecurityEMED · OTC · equity
EMED price & chart
Loading TradingView…
OTC:EMED on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 748,383Source | 1,353,271Source | 1,402,111Source | 1,416,999Source |
| Property, Plant and Equipment, NetUSD | 149,705Source | 705,469Source | 727,344Source | 749,219Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 87,704Source | 368,425Source | 383,170Source | 264,913Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 4,399Source | 9,444Source | 35,085Source | 17,694Source |
| Inventory, NetUSD | 68,517Source | 62,061Source | 218,510Source | 78,712Source |
| Assets, CurrentUSD | 449,185Source | 647,802Source | 674,767Source | 647,179Source |
| Prepaid Expense and Other Assets, CurrentUSD | 288,565Source | — | 38,002Source | 285,860Source |
| Operating Lease, Right-of-Use AssetUSD | 149,493Source | — | — | — |
| Other Assets, NoncurrentUSD | — | — | — | 20,601Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,621,170Source | 3,574,116Source | 2,124,614Source | 2,735,602Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 355,000Source |
| Common Stock, Value, IssuedUSD | 4,631Source | 1,896Source | 876Source | 269Source |
| Additional Paid in CapitalUSD | 23,827,330Source | 22,237,300Source | 20,804,333Source | 7,957,860Source |
| Retained Earnings (Accumulated Deficit)USD | -27,469,748Source | -24,825,041Source | -21,882,712Source | -9,631,732Source |
| Stockholders' Equity Attributable to ParentUSD | -2,872,787Source | -2,220,845Source | -722,503Source | -1,318,603Source |
| Liabilities and EquityUSD | 748,383Source | 1,353,271Source | 1,402,111Source | 1,416,999Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,356,554Source | 2,924,175Source | 1,442,169Source | 2,019,145Source |
| Accounts Payable, CurrentUSD | 239,481Source | 266,744Source | 214,785Source | 262,614Source |
| Other Liabilities, NoncurrentUSD | 8,416Source | 10,234Source | 9,167Source | 15,603Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 38,465Source | 193,848Source | — | — |
| Long-term DebtUSD | 150,000Source | 671,525Source | 702,780Source | 732,266Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -2,641,246Source | -3,468,500Source | -8,480,149Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 4,557Source | 21,875Source | 21,875Source | 21,875Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 715,000Source | 509,603Source | 2,630,144Source | 2,222,856Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -3,200Source | -25,641Source | 17,391Source | 5,792Source |
| Increase (Decrease) in InventoriesUSD | 6,456Source | -156,449Source | 139,798Source | 54,018Source |
| Increase (Decrease) in Accounts PayableUSD | -27,263Source | 51,959Source | -40,529Source | 11,452Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,417,393Source | -773,337Source | -1,193,688Source | -1,336,660Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,744,883Source | — | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 149,705Source | — | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -608,211Source | 758,592Source | 1,311,945Source | 1,601,573Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -280,721Source | -14,745Source | 118,257Source | 264,913Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 87,704Source | 368,425Source | 383,170Source | 264,913Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 40,241Source | 103,819Source | 154,081Source | 48,660Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | 0Source | 0Source | 21,807Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | -355,597Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 1,193,676Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 8,381Source | -1,079,800Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -2,641,246Source | -3,468,500Source | -8,480,149Source | -3,871,724Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -2,644,707Source | -3,576,388Source | -12,250,980Source | — |
| Other Nonoperating Income (Expense)USD | -576,305Source | -1,864,972Source | -4,679,886Source | -705,036Source |
| Other Operating Income (Expense), NetUSD | — | — | 747,395Source | 431,766Source |
| Proceeds from Issuance of Common StockUSD | — | 42,766Source | — | 13,567Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 1,348,808Source | 1,149,844Source | 907,362Source | 737,958Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 3,110,446Source | 2,492,169Source | 4,508,391Source | 3,710,262Source |
| Operating Income (Loss)USD | -2,064,941Source | -1,603,528Source | -3,800,263Source | -3,166,688Source |
| Other Nonoperating Income (Expense)USD | -576,305Source | -1,864,972Source | -4,679,886Source | -705,036Source |
| Net Income (Loss) Attributable to ParentUSD | -2,641,246Source | -3,468,500Source | -8,480,149Source | -3,871,724Source |
| Earnings Per Share, BasicUSD per share | 0Source | -0.03Source | -0.24Source | — |
| Earnings Per Share, DilutedUSD per share | 0Source | -0.03Source | -0.24Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 377,216,319Source | 133,596,295Source | 50,992,414Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 377,216,319Source | 133,596,295Source | 50,992,414Source | — |
| Additional Financial Items | ||||
| Gross ProfitUSD | 1,045,505Source | 888,641Source | 708,128Source | 543,574Source |
| Interest ExpenseUSD | 893,155Source | 791,072Source | 3,313,852Source | 769,591Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -2,644,707Source | -3,576,388Source | -12,250,980Source | — |
| Other Operating Income (Expense), NetUSD | — | — | 747,395Source | 431,766Source |
| Research and Development ExpenseUSD | 231,434Source | 92,299Source | 215,320Source | 31,600Source |